What is the price target for AIKI stock?
7 analysts have analysed AIKI and the average price target is 16.32 USD. This implies a price increase of 358.43% is expected in the next year compared to the current price of 3.56.
NASDAQ:AIKI • US0088753043
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AIKIDO PHARMA INC (AIKI).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-11-11 | HC Wainwright & Co. | Maintains | Buy |
| 2021-10-11 | HC Wainwright & Co. | Initiate | Buy |
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.24M 40.91% | 30K -97.58% | 10K -66.67% | N/A -100.00% | N/A | 20.4M | 21M 2.94% | 22.05M 5.00% | |||
| EBITDA YoY % growth | -2.45M 33.78% | -3.02M -23.27% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -3.82M 34.59% | -4.47M -17.02% | -5.69M -27.29% | N/A -15.11% | -8.874M -44.14% | -18.258M -93.39% | -20.808M -13.97% | -20.706M 0.49% | -17.368M 16.12% | -14.86M 14.44% | |
| Operating Margin | -308.06% | -14,900.00% | -56,900.00% | N/A | N/A | N/A | N/A | -101.50% | -82.71% | -67.39% | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | -1.39 | -4.79 -245.59% | -1.53 68.09% | -0.17 88.97% | -0.02 88.75% | -0.37 -1,837.81% |
All data in USD
| Q4 / 22 | |
|---|---|
| EPS Q2Q % growth | -1.13 -233.00% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -6.834M -164.37% |
All data in USD
7 analysts have analysed AIKI and the average price target is 16.32 USD. This implies a price increase of 358.43% is expected in the next year compared to the current price of 3.56.
AIKIDO PHARMA INC (AIKI) will report earnings on 2023-03-27.
The consensus EPS estimate for the next earnings of AIKIDO PHARMA INC (AIKI) is -1.13 USD and the consensus revenue estimate is 0 USD.